Stock Trading Canary← United States · Coverage record
US · SEC FORM 4
Lycia Therapeutics, Inc.
LYCA · — · CIK 0001806540 · Healthcare · Biotechnology
INSIDER SIGNAL
64.7 / 100
1 buyers · 12 purchase transaction lines · $38.5M gross purchase
WHY THIS SIGNAL?
Buyer breadthLow
Purchase sizeStrong
RoleModerate
RecencyStrong
ConvictionStrong
Score anatomy
Each bar is that part's points in the score; the five parts add up to the score.
Number of buyers+7.0 / 35
Amount bought+24.2 / 25
Buyers' roles+14.0 / 20
How recent+9.5 / 10
Buying against selling+10.0 / 10
What is holding the score back?
- ⚠ Few buyers · 1 insider(s), not 4 or more
- ⚠ Buyers' roles add little · most senior buyer: TenPercentOwner (CEO, chair and 10% owners score lowest)
- ✓ Recent buying · latest purchase 2026-11-02
Average daily trading volume is shown elsewhere on the page as market context; it is not part of the score.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes use transaction dates. Diamonds show later public disclosure dates; the transaction was not public before then. Sales remain context only.
MayJunJulAugSepOctNov
Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P.TenPercentOwner
●◇○◇●◇●●◇●◇●●◇
Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLCTenPercentOwner
○◇
● Purchase▼ Sale○ Other◇ Public disclosure
—
Purchase breadth & concentration
QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. · $38.5M
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-10-23–2026-11-02
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
64.7 / 100
Latest recorded score
↑ +0.3 ptsversus the previous recorded snapshot
- 65.1
- 64.9
- 64.7
- 64.4
- 64.7
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
12Purchases
0Sales
3Other Form 4 lines
4SEC filings · 365 days
BUYING12 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER3 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot detected in parsed evidence
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- —
- 3M
- —
- 6M
- —
- 12M
- —
Volatility & liquidity
- Volatility
- —
- Beta
- —
- Avg daily value
- —
Valuation
- Market cap
- —
- P/E
- —
Fundamentals
- Profit margin
- —
- ROE
- —
- Industry
- Biotechnology
Market data
Price data up to: 2026-11-06 · Price source: OpenBB/yfinance · Status: PASS
Dividends
No cash dividend in the last five years.
Yahoo Finance: cash dividends by ex-dividend date, the latest close, the payout ratio (dividends ÷ 12-month earnings per share) and announced dates; special dividends included, stock dividends and splits not. Not part of any score.
Short interest
The FINRA report lists no short interest for this ticker.
FINRA settlement date: 2026-10-15 · Captured 2026-11-03 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Disclosure date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|---|
| 2026-11-02 | 2026-11-04 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 8,305 | USD 26.95 | USD 223,820 | SEC filing ↗ |
| 2026-10-30 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 9,004 | USD 26.28 | USD 236,653 | SEC filing ↗ |
| 2026-10-29 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 1,000 | USD 26.33 | USD 26,330 | SEC filing ↗ |
| 2026-10-28 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 15,000 | USD 25.45 | USD 381,728 | SEC filing ↗ |
| 2026-10-27 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 39,796 | USD 26.62 | USD 1,059,396 | SEC filing ↗ |
| 2026-10-26 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 1,952,705 | USD 18.04 | USD 35,222,791 | SEC filing ↗ |
| 2026-10-23 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 52,939 | USD 25.91 | USD 1,371,676 | SEC filing ↗ |
Form 4 evidence
15 transaction lines in the latest 365-day window; 15 in local history.
| Trade date | Disclosure date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|---|
| 2026-11-02 | 2026-11-04 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 8,305 | USD 26.95 | USD 223,820 | SEC filing ↗ |
| 2026-10-30 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 9,004 | USD 26.28 | USD 236,653 | SEC filing ↗ |
| 2026-10-29 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 1,000 | USD 26.33 | USD 26,330 | SEC filing ↗ |
Show recent Form 4 evidence (9 grouped rows)
| Trade date | Disclosure date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|---|
| 2026-11-02 | 2026-11-04 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 8,305 | USD 26.95 | USD 223,820 | SEC filing ↗ |
| 2026-10-30 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 9,004 | USD 26.28 | USD 236,653 | SEC filing ↗ |
| 2026-10-29 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 1,000 | USD 26.33 | USD 26,330 | SEC filing ↗ |
| 2026-10-28 | 2026-10-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 15,000 | USD 25.45 | USD 381,728 | SEC filing ↗ |
| 2026-10-27 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 39,796 | USD 26.62 | USD 1,059,396 | SEC filing ↗ |
| 2026-10-26 | 2026-10-28 | Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC | C (C) | Common Stock | 7,025,307 | USD — | USD — | SEC filing ↗ |
| 2026-10-26 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 1,952,705 | USD 18.04 | USD 35,222,791 | SEC filing ↗ |
| 2026-10-26 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | C (C) | Common Stock | 4,779,793 | USD — | USD — | SEC filing ↗ |
| 2026-10-23 | 2026-10-27 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Management XP, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners XP, L.P. | Purchase (P) | Common Stock | 52,939 | USD 25.91 | USD 1,371,676 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-11-05 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | REVIEW MAPPING_REVIEW · mapping-review-required |
| Ticker | LYCA |
| CIK | 0001806540 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| Exchange | — |
Data coverage
| Local Form 4 history | 15 transaction lines from 2026-10-23 to 2026-11-02 12 P purchase lines · 0 S sale lines · 3 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-11-05. Mapping status is an audit field and does not erase SEC filing evidence.